Barclays PLC Trims Stock Position in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Barclays PLC decreased its holdings in Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 13.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 114,026 shares of the company’s stock after selling 17,132 shares during the quarter. Barclays PLC owned 0.31% of Crescent Capital BDC worth $2,109,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Janney Montgomery Scott LLC raised its position in Crescent Capital BDC by 174.1% in the third quarter. Janney Montgomery Scott LLC now owns 47,264 shares of the company’s stock worth $874,000 after acquiring an additional 30,018 shares during the period. Sun Life Financial Inc. increased its stake in shares of Crescent Capital BDC by 20.7% in the 3rd quarter. Sun Life Financial Inc. now owns 2,226,308 shares of the company’s stock worth $41,187,000 after purchasing an additional 382,542 shares in the last quarter. Stifel Financial Corp raised its holdings in Crescent Capital BDC by 53.1% in the 3rd quarter. Stifel Financial Corp now owns 66,470 shares of the company’s stock worth $1,230,000 after purchasing an additional 23,055 shares during the period. International Assets Investment Management LLC purchased a new position in Crescent Capital BDC during the third quarter valued at $1,899,000. Finally, Deerfield Management Company L.P. Series C purchased a new position in Crescent Capital BDC during the second quarter valued at $1,021,000. Hedge funds and other institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Price Performance

Shares of Crescent Capital BDC stock opened at $19.90 on Friday. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14. Crescent Capital BDC, Inc. has a 52 week low of $15.91 and a 52 week high of $20.03. The stock’s 50-day simple moving average is $19.02 and its 200-day simple moving average is $18.73. The company has a market capitalization of $737.53 million, a price-to-earnings ratio of 7.80 and a beta of 0.82.

Crescent Capital BDC Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Tuesday, December 31st will be paid a $0.42 dividend. This represents a $1.68 annualized dividend and a yield of 8.44%. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.07. The ex-dividend date of this dividend is Tuesday, December 31st. Crescent Capital BDC’s dividend payout ratio is presently 65.88%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Keefe, Bruyette & Woods upped their price target on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 25th. LADENBURG THALM/SH SH assumed coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 target price for the company. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $19.17.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.